A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

NCT03427021 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Stopped final study report has been completed and submitted

Conditions

GI Patients on Oxaliplatin Containing Regimen

Interventions

DRUG: Oxaliplatin

Sponsor

Abramson Cancer Center at Penn Medicine